OMRF scientists Tim Griffin and Albert Batushansky are pushing the bounds of a decades-old scientific method to study the origins of osteoarthritis.
therapy
New OMRF findings pave way for more effective lupus treatments
New research from OMRF is taking physicians closer to personalized treatment solutions for patients suffering from lupus.
Searching for new arthritis treatments
Arthritis is the leading cause of disability in adults in the U.S. Understandably, this has led to much concern about the future of arthritis treatment.
OMRF makes potential heart failure breakthrough
Scientists at OMRF have made new findings that could pave the way for the first drug to treat aortic stenosis.
A name for his pain
David Key had never heard of sarcoidosis—until the rare disease stole his health.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
